26 Mar 2020 --- Swiss biotech company Evolva has entered a new collaboration agreement with International Flavors and Fragrances (IFF), a creator of taste, scent and nutrition for consumer products, to further develop and expand commercialization of vanillin. Under the terms of the new agreement, IFF will expand commercialization of the product and Evolva will be responsible to further develop vanillin. Evolva will receive payments for the product manufactured and sold, contributing to reaching cash breakeven by 2023.